<SEC-DOCUMENT>0001213900-25-035955.txt : 20250428
<SEC-HEADER>0001213900-25-035955.hdr.sgml : 20250428
<ACCEPTANCE-DATETIME>20250428133604
ACCESSION NUMBER:		0001213900-25-035955
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250428
FILED AS OF DATE:		20250428
DATE AS OF CHANGE:		20250428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAPIENS INTERNATIONAL CORP N V
		CENTRAL INDEX KEY:			0000885740
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			P8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20181
		FILM NUMBER:		25878822

	BUSINESS ADDRESS:	
		STREET 1:		AZRIELI CENTER
		STREET 2:		26 HAROKMIM ST.
		CITY:			HOLON
		STATE:			L3
		ZIP:			5885800
		BUSINESS PHONE:		97289382777

	MAIL ADDRESS:	
		STREET 1:		AZRIELI CENTER
		STREET 2:		26 HAROKMIM ST.
		CITY:			HOLON
		STATE:			L3
		ZIP:			5885800
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0239719-6k_sapiens.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>

<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>WASHINGTON D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>FORM 6-K</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Report of Foreign Private
Issuer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Pursuant to Rule 13a-16
or 15d-16</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>of the Securities Exchange
Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the month of <b>April
2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Commission File Number&nbsp;<b>000-20181</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SAPIENS INTERNATIONAL
CORPORATION N.V.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Translation of registrant&rsquo;s
name into English)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Azrieli Center</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>26 Harokmim St.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Holon, 5885800 Israel</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Address of principal
executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Form 20-F <font style="font-family: Times New Roman, Times, Serif">&#9746;</font>&nbsp;
Form 40-F&nbsp;<font style="font-family: Times New Roman, Times, Serif">&#9744;</font></p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Exhibits</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt; background-color: white">The
following exhibit is furnished as part of this Form&nbsp;6-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt; background-color: white">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom; width: 9%"><font style="font-size: 10pt"><b>Exhibit</b> &nbsp;</font></td>
    <td style="vertical-align: top; text-align: center; width: 1%">&nbsp;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 90%"><font style="font-size: 10pt"><b>Description</b></font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><font style="font-size: 10pt">99.1</font></td>
    <td style="vertical-align: top; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: bottom"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><A HREF="ea023971901ex99-1_sapiens.htm">Press release</A></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt; background-color: white">&nbsp;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; background-color: white">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD COLSPAN="3"><font style="font-size: 10pt">SAPIENS INTERNATIONAL CORPORATION N.V.</font></td></tr>
  <tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD COLSPAN="3">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <TD><font style="font-size: 10pt">Date: April 28, 2025</font></td>
    <TD><font style="font-size: 10pt">By:</font></td>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><font style="font-size: 10pt">/s/ Roni Giladi</font></td></tr>
  <tr style="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</td>
    <TD STYLE="width: 4%">&nbsp;</td>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-size: 10pt">Roni Giladi</FONT></TD></tr>
  <tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></tr>
</table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea023971901ex99-1_sapiens.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Sapiens Acquires AdvantageGo to Expand Global
P&amp;C Platform with Cutting-Edge Underwriting Workbench &amp; Risk Management Capabilities</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>Acquisition Strengthens
Sapiens&rsquo; Value Proposition Across global Commercial, Specialty, and London Market Segments</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Rochelle Park, New Jersey&ndash; April 28, 2025&nbsp;</B>&mdash;Sapiens
International Corporation&nbsp;(NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced
today that&nbsp;it has signed a definitive agreement for the acquisition of AdvantageGo, a leading commercial insurance software provider
specializing in underwriting workbench solutions for both London and global commercial markets. This strategic acquisition significantly
enhances Sapiens&rsquo; global P&amp;C proposition, adding cutting-edge underwriting workbench capabilities that address one of the most
critical challenges in the P&amp;C industry today: managing, assessing, and writing risk more effectively.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This acquisition aligns with Sapiens&rsquo; strategy to penetrate the
London Specialty Market, and strengthen its support for the reinsurance market.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AdvantageGo is expected to enable Sapiens to enhance its proposition
to the London Specialty Market &ndash; a global hub for complex and high-risk insurance and reinsurance, where brokers and underwriters
negotiate bespoke coverage, primarily through Lloyd&rsquo;s of London and the London Company Market.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of Sapiens&rsquo; vision and strategy, the AdvantageGo underwriting
workbench will be integrated into  Sapiens Insurance Platform for P&amp;C and also offered as a standalone solution. Its innovative
capabilities are expected to provide a compelling value proposition for Sapiens existing P&amp;C customers in EMEA and APAC, operating
in conjunction with Sapiens&rsquo; P&amp;C Platform.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AdvantageGo will also strengthen Sapiens&rsquo; value proposition in
the North American P&amp;C market by enhancing its capabilities for insurers operating in complex specialty and commercial lines.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The underwriting workbench market has grown significantly as
insurers recognize the value of sophisticated decision support tools,&rdquo; said Martin Higgins, Senior Principal, Datos Insights. &ldquo;Sapiens
is breaking ground by being the first major core system vendor to integrate these capabilities directly into their platform. This approach
delivers immediate value for insurers handling complex specialty and commercial lines, addressing a critical gap in the current technology
landscape.&rdquo;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Sapiens&rsquo; growth strategy includes targeted acquisitions
that accelerate our business,&rdquo; said Roni Al-Dor, Sapiens President and CEO. &ldquo;The acquisition of AdvantageGo aligns with our
mission, and expands our portfolio with complementary solutions, extends our global footprint, and deepens our talent pool.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">www.sapiens.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are excited to welcome AdvantageGo&rsquo;s team and loyal
customers to Sapiens,&rdquo; Al-Dor added. &ldquo;We remain committed to investing in AdvantageGo's products, ensuring continuity, innovation,
and long-term value for their customer base.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Joining Sapiens means becoming part of a leading global product
organization that will amplify our capabilities and enhance our solutions, creating greater opportunities for our clients and team,&rdquo;
said Ian Summers, Global Business Leader of AdvantageGo. &ldquo;We look forward to integrating our products into Sapiens Insurance
Platform to deliver a seamless and powerful offering for the European and North American markets. We are committed to ensuring a smooth
transition and continued service excellence for all our customers.&rdquo;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the full year 2024, AdvantageGo revenues were 15 million British
pounds, based on US GAAP, with approximately 50% from recurring revenues, with Gross margin, accretive to Sapiens Gross Margin.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AdvantageGo has made significant strategic investments in its product
in recent years. As a result, of these strategic growth investments the company reported a loss of 9 million British pounds in full year
2024. As Sapiens integrates AdvantageGo&rsquo;s offerings into the broader portfolio and continues to support its market penetration,
we expect AdvantageGo to grow at double-digit rate in 2026. AdvantageGo profitability is expected to improve over time, and become accretive
to Sapiens&rsquo; profit starting in 2027, driven by revenue growth and integration synergies with Sapiens.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transaction is expected to be consummated in the coming weeks.
Upon completion, Advantage Go will become wholly owned by Sapiens. The acquisition of Advantage Go is structured as a <FONT STYLE="font-family: Times New Roman, Times, Serif">cash
deal, based on an enterprise value of 43 million British pounds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BDA Partners and William Blair acted as financial advisors to Coforge.
JSA acted as legal advisor to Coforge, and Meitar acted as legal advisor to Sapiens in connection with the transaction.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Sapiens</B>&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global
leader in intelligent insurance SaaS-based software solutions. With Sapiens&rsquo; robust platform, customer-driven partnerships, and
rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace.
Our SaaS-based Solutions help insurers harness the power of AI and advanced automation to support core solutions for property and casualty,
workers&rsquo; compensation, and life insurance, including reinsurance, financial &amp; compliance, data &amp; analytics, digital, and
decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative
offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with
our customers for their entire transformation journey and is continuously innovating to ensure their success.&#8239;&#8239;&#8239;For
more information visit&#8239;https://sapiens.com&#8239;or follow us on&#8239;LinkedIn.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">www.sapiens.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About AdvantageGo</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With over 30 years of industry experience, AdvantageGo delivers a single,
modular platform designed specifically for specialty and commercial (re)insurers that empowers underwriters with an underwriting workbench,
exposure management and policy administration modules that drive the complete policy lifecycle from pre-bind risk and portfolio assessment
value to policy renewals and beyond. Together with the AdvantageGo ecosystem of third-party data sources, applications, and systems integrators,
underwriters have an integrated flow of timely, data-driven underwriting insights for improved risk selection in the moments that matter.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Learn more at www.advantagego.com or LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor and Media Contact&#8239;</B>&nbsp;<BR>
Yaffa Cohen-Ifrah&#8239;&nbsp;<BR>
Sapiens Chief Marketing Officer and Head of Investor Relations&#8239;&#8239;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mobile: +1 917 533 4782&nbsp;<BR>
Email:&#8239;Yaffa.cohen-ifrah@sapiens.com<B>&#8239;</B>&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">www.sapiens.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B>&#8239;&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain matters discussed in this press release that are incorporated
herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of
the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs,
assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the
use of the words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;plan&rdquo; and similar expressions. Such statements reflect our current views with respect to future events and are subject to
certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements
to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements,
including, but not limited to:&#8239; the degree of our success in our plans to leverage our global footprint to grow our sales&#894;
the degree of our success in integrating the companies that we have acquired through the implementation of our M&amp;A growth strategy&#894;
the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential
new solutions&#894; our lengthy and complex sales cycles, which do not always result in the realization of revenues&#894; the degree of
our success in retaining our existing customers or competing effectively for greater market share&#894;&#8239;the global macroeconomic
environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements,
and uncertain economic conditions, and their impact on our revenues, profitability and cash flows;&#8239;difficulties in successfully
planning and managing changes in the size of our operations&#894; the frequency of the long-term, large, complex projects that we perform
that involve complex estimates of project costs and profit margins, which sometimes change mid-stream&#894; the challenges and potential
liability that heightened privacy laws and regulations pose to our business&#894; occasional disputes with clients, which may adversely
impact our results of operations and our reputation&#894; various intellectual property issues related to our business&#894; potential
unanticipated product vulnerabilities or cybersecurity breaches of our or our customers&rsquo; systems&#894; risks related to the insurance
industry in which our clients operate&#894; risks associated with our global sales and operations, such as changes in regulatory requirements,
wide-spread viruses and epidemics like the coronavirus epidemic,&#8239; and fluctuations in currency exchange rates&#894; and risks related
to our principal location in Israel and our status as a Cayman Islands company.&#8239;&#8239;&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While we believe such forward-looking statements are based on reasonable
assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual
results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under
the heading &ldquo;Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2023, to be filed in the near
future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking
statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and
events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake
no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes
in our expectations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">www.sapiens.com</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  : )X# 2(  A$! Q$!_\0
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M_BRS;4+#1-6\1ZAI=O%K7B?Q-XC-]=17,U]::2;/2(-/TBW^B1_P:S?\%12
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M(LM7FT]O"WBG2O[1%A="RU)-/DTHW4"6<M_#>W-E;W/Z^?!;_@I[\8?VYO\
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M_B%7_P""G?\ T%_V8_\ PZWB?_YVU?:'_!0W]C_XV_\ !/G_ (-WOAI^S?\
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IYC*$:.50?M(X/!4<'BL3&LWRP^L8=1M::B_:5959TX1E"C&/M)L__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  # M # 2(  A$! Q$!_\0
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M$%<^$="/!@OO7_D-:W_\L:KOX.T$L<P7_..FN:Z.P]-2&/PHHKZ7"YGF.O\
MMV*_\&^?_7H^>KY!D?,O^$G ;?\ 0.__ )H*$O@S0,_ZG4>K?\Q_7_7_ +"=
M9TO@KP]DGR=2ZXX\0>(1QSZ:I^O6BBN]9KF2M;'XI:/_ )>_XO\ IT*CD&27
M_P"13@-U_P N'V?_ %$%9O!/AWC]SJ7+#/\ Q4/B+_Y:U$W@CPZ6)\G4^O\
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M]3M49^ WPX/6+QO_ .'9^+'_ ,VU%%9/,<?SI?7,3;33VGK_ -.SGE\+]/\
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M]!>(_P#!G_W,CDA=>['9]/3S(F^ 7PV!($?CK_P[WQ=]/^QYJ/\ X4!\-?\
MGEXZ_P##O_%[_P";FBBI>/QS<;XO$;/_ )>>G_3LPE3A=^Y'=]//U$_X9_\
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3LRA1I.5.].#_ 'L/L_WH?WC_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
